✦ LIBER ✦

Procedural learning in schizophrenia after 6 months of double-blind treatment with olanzapine, risperidone, and haloperidol

✍ Scribed by ScotE. Purdon; Neil Woodward; StacyR. Lindborg; Emmanuel Stip

Publisher: Springer
Year: 2003
Tongue: English
Weight: 189 KB
Volume: 169
Category: Article
ISSN: 0033-3158
DOI: 10.1007/s00213-003-1505-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Olanzapine, risperidone and haloperidol

Olanzapine, risperidone and haloperidol in the treatment of adolescent patients with schizophrenia

✍ D. Gothelf; A. Apter; J. Reidman; A. Brand-Gothelf; Y. Bloch; G. Gal; L. Kikinzo 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 155 KB

A comparison of the efficacy and safety

A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration

✍ C. W. Ritchie; E. Chiu; S. Harrigan; S. Macfarlane; M. Mastwyk; G. Halliday; H. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 3 views

Background Following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effect

A 6-month, randomized, double-blind, pla

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease

✍ D.P. Devanand; Gregory H. Pelton; Karine Cunqueiro; Harold A. Sackeim; Karen Mar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## Objective In patients with Alzheimer's disease (AD) with psychosis or agitation that respond to haloperidol treatment, to evaluate the risk of relapse following discontinuation. ## Methods In outpatients with AD with symptoms of psychosis or agitation, responders to 20 weeks of ha

The efficacy and safety of diacerein in

The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double-blind, placebo-controlled study with primary end points at two months after the end of a three-month treatment period

✍ Karel Pavelka; Tomáš Trč; Karel Karpaš; Petr Vı´tek; Marie Sedláčková; Věra Vlas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 3 views

Very early treatment with infliximab in

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve-month randomized, double-blind, placebo-controlled trial

✍ Mark A. Quinn; Philip G. Conaghan; Philip J. O'Connor; Zunaid Karim; Adam Greens 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views